InfuCare Rx is pleased to announce its selection as a limited distribution provider of VYVGART™. VVGART™ has been approved by the Food & Drug Administration (FDA) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for the antiacetylcholine receptor (AChR) antibody. InfuCare Rx is a leading data-driven nationwide specialty infusion provider. […]
Read more